Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Operating Income: 2012-2024

Historic Operating Income for Sunshine Biopharma (SBFM) over the last 11 years, with Dec 2024 value amounting to -$5.8 million.

  • Sunshine Biopharma's Operating Income rose 1.78% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.5 million, marking a year-over-year decrease of 31.80%. This contributed to the annual value of -$5.8 million for FY2024, which is 21.46% down from last year.
  • Sunshine Biopharma's Operating Income amounted to -$5.8 million in FY2024, which was down 21.46% from -$4.8 million recorded in FY2023.
  • Over the past 5 years, Sunshine Biopharma's Operating Income peaked at -$576,874 during FY2020, and registered a low of -$27.0 million during FY2022.
  • Its 3-year average for Operating Income is -$12.5 million, with a median of -$5.8 million in 2024.
  • In the last 5 years, Sunshine Biopharma's Operating Income crashed by 1,006.53% in 2022 and then spiked by 82.28% in 2023.
  • Yearly analysis of 5 years shows Sunshine Biopharma's Operating Income stood at -$576,874 in 2020, then crashed by 322.99% to -$2.4 million in 2021, then crashed by 1,006.53% to -$27.0 million in 2022, then skyrocketed by 82.28% to -$4.8 million in 2023, then dropped by 21.46% to -$5.8 million in 2024.